Clinical Neuropsychopharmacology and Therapeutics
Online ISSN : 1884-8826
ISSN-L : 1884-8826
A case of hyperprolactinemia and delusion of pregnancy during clozapine treatment
Keigo OndaTakayuki YukawaEmiko InoueRyusuke TsuboyaMasashi SakaueToshiyuki Someya
Author information

2021 Volume 12 Pages 1-4


Clozapine (Clozaril, Novartis) is classified as a prolactin-sparing antipsychotic, so clozapine-induced hyperprolactinemia is rare. Herein, however, we present a case of severe hyperprolactinemia with delusion of pregnancy during the use of clozapine. We discuss various factors involved in the background of hyperprolactinemia and delusion of pregnancy. While clozapine-induced hyperprolactinemia is rare, the adverse events of this condition can be clinically important in the short- and long-term. In Japan, the measurement of prolactin levels is not a required item in the Clozaril Patient Monitoring Service (CPMS, Novartis), so the risk of hyperprolactinemia tends to be easily overlooked. We hope this case report will help to alert colleagues to the risk of hyperprolactinemia during clozapine use.

Content from these authors
© 2021 The Japanese Society of Clinical Neuropsychopharmacology
Next article